Get the app!
Back to Trades

Hopkinson Craig C.

EVP R&DChief Medical OfficerCIK 0001730048

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
14
Buy transactions
0
Sell transactions
14
Companies
1
Active
2025–2026

Hopkinson Craig C., EVP R&D, Chief Medical Officer, has filed 14 SEC reports (2025–2026), all concentrated in Alkermes plc. (ALKS), totaling $7.8M in disclosed volume. Weighing $0 bought versus $3.1M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

14 loaded
Jul 1ALKS
Alkermes plc.
Hopkinson Craig C.EVP R&D, Chief Medical OfficerSell$463.6K
Jun 1ALKS
Alkermes plc.
Hopkinson Craig C.EVP R&D, Chief Medical OfficerSell$375.0K
May 1ALKS
Alkermes plc.
Hopkinson Craig C.EVP R&D, Chief Medical OfficerSell$300.6K
Apr 1ALKS
Alkermes plc.
Hopkinson Craig C.EVP R&D, Chief Medical OfficerSell$319.6K
Mar 4ALKS
Alkermes plc.
Hopkinson Craig C.EVP R&D, Chief Medical OfficerSell$267.5K
Feb 25ALKS
Alkermes plc.
Hopkinson Craig C.EVP R&D, Chief Medical OfficerExercise$109.9K
Feb 20ALKS
Alkermes plc.
Hopkinson Craig C.EVP R&D, Chief Medical OfficerExercise$221.2K
Feb 2ALKS
Alkermes plc.
Hopkinson Craig C.EVP R&D, Chief Medical OfficerSell$305.4K
Jan 8ALKS
Alkermes plc.
Hopkinson Craig C.EVP R&D, Chief Medical OfficerSell$150.0K
Jan 2ALKS
Alkermes plc.
Hopkinson Craig C.EVP R&D, Chief Medical OfficerSell$112.0K
Dec 5ALKS
Alkermes plc.
Hopkinson Craig C.EVP R&D, Chief Medical OfficerSell$112.4K
Dec 1ALKS
Alkermes plc.
Hopkinson Craig C.EVP R&D, Chief Medical OfficerSell$117.2K
Nov 3ALKS
Alkermes plc.
Hopkinson Craig C.EVP R&D, Chief Medical OfficerSell$273.4K
Oct 15ALKS
Alkermes plc.
Hopkinson Craig C.EVP R&D, Chief Medical OfficerSell$283.8K

14 filings